INARI MEDICAL INC (NARI)

Company Profile

Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 1,100 full-time employees. The company went IPO on 2020-05-22. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of thrombus from the peripheral vasculature. Its ProTrieve sheath is used for the removal of thrombus from the peripheral vasculature through aspiration. The company also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss. The company also offers LimFlow System for Transcatheter Arterialization of the Deep Veins (TADV).

Company Info

INARI MEDICAL INC

6001 Oak Canyon, Suite 100

Irvine CALIFORNIA 92618

P: 19499234747

CEO: William Hoffman

Employees: 1100

Website: https://www.inarimedical.com